Letermovir
| CAS No. | 917389-32-3 | Cat. No. | BCP28231 |
| Name | Letermovir | ||
| Synonyms | MK-8828; MK 8828; MK8828; AIC-246; AIC 246; AIC246; | ||
| Formula | C29H28F4N4O4 | M. Wt | 572.56 |
| Description | Letermovir, also known as MK-8828 and AIC-246, is an antiviral drug that is being developed for the treatment of cytomegalovirus (CVM) infections. Letermovir has been tested in CMV infected patients with allogeneic stem cell transplants and may also be useful for other patients with a compromised immune system such as those with organ transplants or HIV infections. | ||
| Pathways | Microbiology/Virology | ||
| Targets | CMV | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.